However, CD4+CD25+ Treg cells from Y27-treated GVHD mice had enhanced suppressive activity, particularly at 20 and 40 mg/kg (71.24%, P < 0.01; 59.58%, P < 0.05). The gene discussed is CD4; the disease is graft versus host disease.